e2609
Showing 1 - 10 of 10
Alzheimer, Dementia, Alzheimer Type Trial in United States (E2609, Placebo)
Terminated
- Alzheimer Disease
- Dementia, Alzheimer Type
- E2609
- Placebo
-
Bellflower, California
- +20 more
Mar 4, 2021
Early Alzheimer's Disease Trial in Miami, Orlando, Minneapolis (E2609)
Completed
- Early Alzheimer's Disease
- E2609
-
Miami, Florida
- +2 more
Jun 7, 2017
Healthy Participants Trial in Fukuoka (E2609, Placebo)
Completed
- Healthy Participants
- E2609
- Placebo
-
Fukuoka, JapanEisai Trial Site
Apr 14, 2017
Alzheimer's Disease Trial in Glendale, Baltimore (E2609, Placebo for E2609)
Completed
- Alzheimer's Disease
- E2609
- Placebo for E2609
-
Glendale, California
- +1 more
Dec 29, 2016
Metabolism and Elimination Trial in Madison (E2609)
Completed
- Metabolism and Elimination
- E2609
-
Madison, Wisconsin
- +1 more
Jan 6, 2016
Healthy Trial in Orlando (E2609, Placebo)
Completed
- Healthy
- E2609
- Placebo
-
Orlando, FloridaCompass Research Phase 1, LLC
Nov 2, 2015
Healthy Subjects Trial in San Antonio (Placebo, E2609, Moxifloxacin)
Completed
- Healthy Subjects
- Placebo
- +2 more
-
San Antonio, Texas(unnamed)
Nov 2, 2015
Healthy Subjects Trial in San Antonio (E2609, itraconazole, rifampin)
Completed
- Healthy Subjects
- E2609
- +4 more
-
San Antonio, TexasWCT Early Development
Nov 2, 2015
Healthy Subjects Trial in Glendale (E2609, Placebo)
Completed
- Healthy Subjects
- E2609
- Placebo
-
Glendale, California(unnamed)
Nov 2, 2015
Alzheimer's Disease Trial in Glendale (E2609)
Completed
- Alzheimer's Disease
- E2609
-
Glendale, CaliforniaCalifornia Clinical Trials/Parexel
May 20, 2013